You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AMRX Award Disclosure
Patel Gautam · SEC Form 4 · Filed Aug 12, 2026
Award
Reported value range
Not reported
Patel Gautam Director
AMRX
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
AMRX daily price context
Close on/before transaction
$17.88
Aug 10, 2026
First close after public filing
$17.27
Aug 13, 2026
30-day return after filing
-1.51%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 283,632 shares
- SEC ownership
- Indirect
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001628280-26-056288
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. AMRX Current | Award | Aug 10, 2026 | Not reported |